The lack of tumor-specific surface antigens has limited the application of CAR T cells in solid tumors. A new AND-gated CAR T cell system repurposes proximal T cell signaling proteins to restrict activation to dual antigen encounter, mitigating on-target, off-tumor toxicity while preserving antitumor efficacy in preclinical models.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tousley, A. M. et al. Nature 615, 507–516 (2023).
June, C. H. & Sadelain, M. N. Engl. J. Med. 379, 64–73 (2018).
Kloss, C. C., Condomines, M., Cartellieri, M., Bachmann, M. & Sadelain, M. Nat. Biotechnol. 31, 71–75 (2013).
Roybal, K. T. et al. Cell 167, 419–432 e416 (2016).
Cho, J. H., Collins, J. J. & Wong, W. W. Cell 173, 1426–1438 e1411 (2018).
Lajoie, M. J. et al. Science 369, 1637–1643 (2020).
Srivastava, S. et al. Cancer Cell 35, 489–503 e488 (2019).
Majzner, R. G. et al. Cancer Discov. 10, 702–723 (2020).
Hamieh, M. et al. Nature 568, 112–116 (2019).
Zhao, Z. et al. Cancer Cell 28, 415–428 (2015).
Daniels, K. G. et al. Science 378, 1194–1200 (2022).
Kawalekar, O. U. et al. Immunity 44, 380–390 (2016).
Mackensen, A. et al. Nat. Med. 28, 2124–2132 (2022).
Rurik, J. G. et al. Science 375, 91–96 (2022).
Amor, C. et al. Nature 583, 127–132 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
P.B. declares no financial interests. J.F. is listed as co-inventor of several patents on CAR technologies unrelated to the subject matter of this study.
Rights and permissions
About this article
Cite this article
Bucher, P., Feucht, J. LINKing signaling domains to enhance CAR T cells. Nat Cancer 4, 447–449 (2023). https://doi.org/10.1038/s43018-023-00538-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-023-00538-7